Join to View Full Profile
309 E Farwell RdSuite 100Spokane, WA 99218
Phone+1 509-464-2873
Fax+1 509-466-0914
Dr. Anthony is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1994 - 1997
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1989 - 1992
Philadelphia College of Osteopathic MedicineClass of 1988
Certifications & Licensure
TN State License 2021 - 2026
TX State License 2017 - 2026
AZ State License 2006 - 2025
WA State License 1998 - 2025
VT State License 1996 - 1998
PA State License 1989 - 1994
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer Start of enrollment: 2003 May 01
- A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors Start of enrollment: 2011 Mar 01
- Safety Study of PLX108-01 in Patients With Solid Tumors Start of enrollment: 2009 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsCSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden.Charles Peterfy, Yan Chen, Peter Countryman, Bartosz Chmielowski, Stephen P Anthony
Future Oncology. 2022-04-01 - 3 citationsA prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemiaJoshua F. Zeidner, Tara L. Lin, Carlos E. Vigil, Gil Fine, M. Yair Levy
Blood Cancer Journal. 2021-10-30 - 12 citationsResults from Phase 1 Extension Study Assessing Pexidartinib Treatment in 6 cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCTWilliam D. Tap, Arun S. Singh, Stephen P. Anthony, Mike Sterba, Chao Zhang
Clinical Cancer Research. 2021-10-29
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
